The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol. - Wikidata - awgldk - TriplyDB

The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol.

The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol.

http://www.wikidata.org/entity/Q37321874

about

Consequences of Facial Hemangioma with Regard to Dental Treatment Impact of pharmaceutical care on cardiovascular risk among older HIV patients on antiretroviral therapy.Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres.

P2860

Q33661014-DE99808F-3CFD-4FD3-A19E-E94BE06E4EBC Q39172811-5D9BACBE-B022-4923-89DB-593C25A741D1 Q49384897-E79DDF23-6894-4402-9504-BE5D68628A10

P2860

The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol.

http://www.wikidata.org/entity/Q37321874

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Role of the Pharmacist in ...... Hemangioma Using Propranolol.

@en

The Role of the Pharmacist in ...... Hemangioma Using Propranolol.

@nl

type

label

The Role of the Pharmacist in ...... Hemangioma Using Propranolol.

@en

The Role of the Pharmacist in ...... Hemangioma Using Propranolol.

@nl

prefLabel

The Role of the Pharmacist in ...... Hemangioma Using Propranolol.

@en

The Role of the Pharmacist in ...... Hemangioma Using Propranolol.

@nl

P1433

Q37321874-DCCAF26B-F165-452C-8416-A8DD19A9B060

P1476

Q37321874-BBB609EB-45AB-4CC6-B8FA-5EE1BB513815

P2093

Q37321874-DE16022C-D50D-47EE-917A-7579AF094FB1

Q37321874-DED5E6C3-5C99-452C-8463-8CDEF72CC017

Q37321874-DF930866-C58C-4350-868D-95AE8A1701B9

Q37321874-FE199EAC-4F7B-408E-9DAE-DEF7B81E2496

P2860

Q37321874-11207F8A-3041-4229-A6B1-F2409D2B6FDB

Q37321874-23595124-CB54-4FD0-8634-09C13214A991

Q37321874-2EAF61E8-9378-4588-85D3-46736340DF73

Q37321874-495CF5C1-125B-46C5-9C67-7B815F9D8D16

Q37321874-7112CD14-159F-4920-B589-7808C1933F55

Q37321874-745C331F-2223-482F-A9B6-0C9C82A7B21E

Q37321874-79069277-D1C9-44A8-981C-4A0A6211CCC3

Q37321874-8092BB8B-9643-4173-BB0A-F6B09BA09FEF

Q37321874-ADB2EAD4-9FE6-442E-94B6-7785D1832B82

Q37321874-B20CDE82-D8BA-4536-BE87-8B2774AEBA95

P2888

Q37321874-F29EE297-7518-43E0-922B-762BCAA544B6

P304

Q37321874-3A09AFD4-1084-4F20-8CDA-981AFEEDE310

P31

Q37321874-0A51D9FE-F77F-4FA0-AC6C-706F7C6CA667

P356

Q37321874-7D9BDD2E-4A52-494F-9742-232764422D4F

P407

Q37321874-DFD6E4CA-5929-460C-8F51-43F1B57DE213

P433

Q37321874-BA201CE0-7F8A-4ABD-96A1-C9EC919C36E9

P478

Q37321874-EED8FE85-1732-414A-BDF4-35CA6B98AAE0

P50

Q37321874-C3AF7A51-166E-409C-B5C2-F677185E25C7

P577

Q37321874-BD5772C9-1E7C-4DF5-9498-C6C8DAA4EF91

P698

Q37321874-F3032F3C-4CD2-4E8D-9CC5-390593C9C9BE

P932

Q37321874-E0F0CA42-C119-4768-8D26-F1DE65DFB1E5

P356

S12325-016-0391-9

P1433

Advances in Therapy

P1476

The Role of the Pharmacist in ...... e Hemangioma Using Propranolol

@en

P2093

Esbeydy Garcia

http://www.w3.org/2001/XMLSchema#string

Hermelinda De la Cruz

http://www.w3.org/2001/XMLSchema#string

Jose Sanchez-Palacio

http://www.w3.org/2001/XMLSchema#string

Samuel Melendez-Lopez

http://www.w3.org/2001/XMLSchema#string

P2860

Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.

Drug therapy management: an empirical report of drug therapy problems, pharmacists' interventions, and results of pharmacists' actions.

A randomized, controlled trial of oral propranolol in infantile hemangioma.

Therapeutic Effect of Propranolol in Mexican Patients with Infantile Hemangioma

Systematic reviews of pharmacy practice research: methodologic issues in searching, evaluating, interpreting, and disseminating results.

Infantile hemangiomas: an update on pathogenesis and therapy.

Propranolol and infantile hemangiomas four years later: a systematic review.

Stability of propranolol in extemporaneously compounded suspensions.

Pharmaceutical intervention upon hospital discharge to strengthen understanding and adherence to pharmacological treatment.

Clinical and economic outcomes of medication therapy management services: the Minnesota experience.

P2888

s12325-016-0391-9

P304

1831-1839

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-016-0391-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27461120

http://www.w3.org/2001/XMLSchema#string

P932

5055552

http://www.w3.org/2001/XMLSchema#string